Congenitally corrected transposition of great vessels with infundibular pulmonary stenosis with ventricular septal defect, presenting with atypical atrioventricular nodal reentrant tachycardia: a rare association

Introduction

Congenitally corrected transposition of great vessels (CCTGV) is a rare congenital heart disease (CHD) accounting for <1% of all CHDs. It is characterized by double discordance – atrioventricular and ventriculoarterial – which physiologically corrects the discordance intrinsic to each malalignment.¹ About 75% of patients have associated VSD, 75% have subpulmonary stenosis and 75% have left-sided Ebsteins’s-like valves.² CCTGV with infundibular pulmonary stenosis (PS) with ventricular septal defect (VSD) forms part of Fallot’s physiology. Fallot’s physiology is a group of cyanotic CHDs associated with PS and VSD. Entities under Fallot’s physiology are said to be more common in patients with dextrocardia and situs solitus.³ CCTGV with PS with VSD is a rare cyanotic CHD constituting 0.8% of all CHDs. It is associated with bradyarrhythmias like atrioventricular (AV) blocks – first-degree AV block develops in 50% and complete AV block in 25% patients.⁴ Tachyarrhythmias like atrioventricular reentrant tachycardia (AVRT) can occur from the left-sided accessory pathways. But atrioventricular nodal reentrant tachycardia (AVNRT) in such patients is very rare. Unusual forms of AVNRT can occur in CCTGV in the context of 2 atrioventricular nodes, both of which have the opportunity for reentry using separate atrial connections. Both atrioventricular nodes can be connected by a Monckeberg sling and participate together in an atrial connection to either of the atrioventricular nodes.⁵

Case history

We report the case of a 30-year-old female, a known case of CHD, not corrected surgically or not on any drugs, who presented with sudden onset of palpitations and fatigue. She gave a 22-year long history of fatigue which had progressed from New York Heart Association (NYHA) class 1 to 3, a 12-year history of breathlessness which had progressed from NYHA class 1 to 3 and a 9-year history of cyanosis with no history suggestive of squatting episodes. She had tolerated 3 pregnancies uneventfully and delivered in a Primary Health Centre. Family history was not significant.

Her electrocardiogram (ECG) showed features of atypical AVNRT and she was hemodynamically stable (Figure 1). She was pharmacologically cardioverted to normal sinus rhythm with injection of adenosine 6 mg. The post cardioversion ECG showed dextrocardia but no evidence of preexcitation (Figure 2).

Figure 1 ECG showing narrow complex tachycardia with features of dextrocardia suggestive of atypical AVNRT. Abbreviations: ECG, electrocardiogram; AVNRT, atrioventricular nodal reentrant tachycardia.

Figure 2 Post-cardioversion ECG showing P waves before the QRS complexes, no evidence of preexcitation and T-wave inversions from V1 to V6. Abbreviation: ECG, electrocardiogram.

On examination, she had central cyanosis and grade 2 clubbing in all 4 limbs and raised jugular venous pressure (JVP) – 6 cm above sternal angle. Cardiac examination revealed dextrocardia, situs solitus, normal S1, single S2, an ejection systolic murmur, grade 3/6 intensity and best heard in left second intercostal space. Chest X-ray confirmed situs solitus and dextrocardia (Figure 3).

Figure 3 Chest X-ray PA view demonstrating dextrocardia, situs solitus, cardiomegaly and decreased pulmonary vascular markings. Abbreviations: PA, postero-anterior view; R, right side.

Transthoracic echocardiography confirmed the diagnosis of CCTGV with infundibular PS and VSD (Figure 4).

Figure 4 Apical 4-chamber view demonstrating dextrocardia with right atrium connected to left ventricle and left atrium connected to right ventricle indicated by the presence of moderator band in the right ventricle and apically placed tricuspid valve. Abbreviations: MRV, morphologic right ventricle; MLV, morphologic left ventricle; RA, right atrium; LA, left atrium; VSD, ventricular septal defect.

She was put on tablet diltiazem 60 mg once a day as it was the first episode of paroxysmal supraventricular tachycardia (PSVT) and was hemodynamically stable during the episode. Patient was followed up for 3 months. She did not have any other episode of palpitations or documented PSVT. This was the first episode of palpitations and also the first documented PSVT and the first cardioversion. As the patient had infrequent, well-tolerated AVNRT, she was put on tablet diltiazem as part of management strategy.

Ethics

Written informed consent was provided by the patient to have the case details and accompanying images published.

Discussion

CCTGV with VSD with PS is a rare congenital anomaly. It can persist till the fourth decade of life with minimal symptoms and slow progression without surgical correction. Though bradyarrhythmias, heart blocks and preexcitation are said to be common in these patients, the patients can rarely present with atypical AVNRT as in the present case. Three types of AVNRT are described. Typical or slow/fast AVNRT is the most prevalent type accounting for 85–90% of cases. Atypical AVNRT constitutes the other 10–15% of the cases, which is further differentiated into slow/slow and fast/slow AVNRT. In typical AVNRT, anterograde conduction is through slow pathway and retrograde conduction is through fast pathway; hence, the RP interval is short. But in atypical AVNRT, the anterograde conduction is through fast pathway and retrograde conduction is through slow pathway; hence, it is a type of long RP tachycardia.⁶ Catheter ablation of AVNRT in CCTGV is difficult due to the complex anatomy. Radiofrequency ablation using a left septal approach corresponding to the inferior border of coronary sinus ostium of the AVNRT is feasible in patients with AVNRT.⁷ Infrequent, well-tolerated AVNRT can be followed without specific therapy or treated with beta blockers or non-dihydropyridine calcium channel blockers.⁸

Acknowledgments

This paper was presented at the 33rd Annual Conference of Association of Physicians of India, Karnataka chapter, KAPICON-2015 at Vijayapura, India, as a poster presentation with interim findings. The poster’s abstract was published in “Poster Abstracts” in The Journal of the Association of Physicians of India, January 2016, volume 64. Hyperlink – http://japi.org/january_2016/poster/01_Cardiology.html.

Disclosure

The author reports no conflicts of interest in this work.

References

1.		Perloff JK. Congenitally corrected transposition of great arteries. In: Perloff JK, editor. The Clinical Recognition of Congenital Heart Disease. 5th ed. Philadelphia: Elsevier Saunders; 2003, p. 62.
2.		Brown DW, Fulton DR. Congenital heart disease in children. In: Fuster V, Walsh RA, Harrington RA, et al., editors. Hurst’s the Heart. 13th ed. Beijing: McGraw-Hill; 2011, pp.1872,1873.
3.		Krishna Kumar R, Tandon R. Disorders of cardiovascular system. In: Ghai OP, Paul VK, Bagga A, editors. Ghai Essential Pediatrics. 7th ed. New Delhi: CBS Publishers and Distributors; 2009, pp 412–414.
4.		Webb GD. Congenital heart disease. In: Mann DL, Zipes DP, Libby P, Bonnow RO, editors. Braunwald’s Heart Disease. 10th ed. Philadelphia: Elsevier Saunders; 2015.
5.		Noheria A, Aasirvatham SJ, Mcleod CJ. Unusual atrioventricular re-entry tachycardia in congenitally corrected transposition of great arteries, a novel site for catheter ablation. Circulation. 2016;9:e004120.
6.		Calkins H. Supraventricular tachycardia: atrioventricular nodal re-entry and Wolf-Parkinson-White syndrome. In: Fuster V, Walsh RA, Harrington RA, et al., editors. Hurst’s the Heart. 13th ed. Beijing: McGraw-Hill; 2011.
7.		Ma J, Bian C, Ying Z-Q. Successful ablation of atrioventricular nodal re-entrant tachycardia in a patient with congenitally corrected transposition of the great vessels and situs inversus. Intern Med. 2014;53:1519–1522.
8.		Blomstron-Lundquist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and European Society of Cardiology Committee for Practice Guidelines. Circulation. 2003;108(15):1871–1909.